Glyburide inhibits non-enzymatic glycation of HSA: An approach for the management of AGEs associated diabetic complications. 2021

Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
Department of Agricultural Microbiology, Aligarh Muslim University, Aligarh, UP 202002, India.

Advanced glycation endproducts (AGEs) are the final product of glycation, highly reactive in nature and contribute directly or indirectly to numerous complications related to diabetes. In this study, the antiglycation activity of glyburide was investigated using HSA as model protein, both against glucose and methylglyoxal mediated glycation. The possible mechanism of action was also deciphered using biophysical and computational tools. Approximately 70% inhibition of both early and advanced glycation end products were recorded in the presence of glyburide. Free lysine modification was reduced by glyburide treatment and improvement in biochemical markers such as free thiol groups and carbonyl content was observed. Interaction studies revealed that glyburide showed moderate to strong binding affinity towards HSA with binding constant in the order of 106 M-1. The interaction of glyburide with HSA was entropically favourable and spontaneous in nature. Molecular dynamics simulation deciphered that glyburide-HSA complex was quite stable where RMSD, RMSF, Rg, SASA, and secondary structure of HSA remained approximately same over the entire simulation period. The average binding energy of the MD simulation for glyburide-HSA complex was found to be -15.386 kJ mol-1. The findings demonstrate the antiglycation potential of glyburide and its possible mechanism of action.

UI MeSH Term Description Entries
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum
D017127 Glycation End Products, Advanced A heterogeneous group of compounds derived from rearrangements, oxidation, and cross-linking reactions that follow from non-enzymatic glycation of amino groups in PROTEINS; LIPIDS; or NUCLEIC ACIDS. Their accumulation in vivo accelerates under hyperglycemic, oxidative, or inflammatory conditions. Heat also accelerates the formation of advanced glycation end products (AGEs) such seen with the browning of food during cooking. Advanced Glycation End Product,Advanced Glycation Endproduct,Advanced Maillard Reaction End Product,Glycated Lipids,Glycotoxins,Maillard Product,Maillard Reaction End Product,Maillard Reaction Product,Advanced Glycation End Products,Advanced Glycation Endproducts,Advanced Maillard Reaction End Products,Glycation Endproducts, Advanced,Maillard Products,Maillard Reaction End Products,Maillard Reaction Products,Glycation Endproduct, Advanced,Lipids, Glycated,Product, Maillard Reaction,Products, Maillard,Products, Maillard Reaction,Reaction Products, Maillard
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D048909 Diabetes Complications Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. Complications of Diabetes Mellitus,Diabetes-Related Complications,Diabetic Complications,Diabetes Complication,Diabetes Mellitus Complication,Diabetes Mellitus Complications,Diabetes Related Complications,Diabetes-Related Complication,Diabetic Complication
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics

Related Publications

Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
February 2008, Saudi medical journal,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
April 2012, Amino acids,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
March 2016, Food & function,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
February 2005, Current diabetes reviews,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
February 1999, Diabetes, nutrition & metabolism,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
December 2006, Indian journal of biochemistry & biophysics,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
April 1992, Atherosclerosis,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
August 2008, Arquivos brasileiros de endocrinologia e metabologia,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
October 2025, Journal of biomolecular structure & dynamics,
Faizan Abul Qais, and Tarique Sarwar, and Iqbal Ahmad, and Rais Ahmad Khan, and Syed Ali Shahzad, and Fohad Mabood Husain
January 2024, Journal of biomolecular structure & dynamics,
Copied contents to your clipboard!